Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A LAMA2-related Muscular Dystrophy Study: Brain Magnetic Resonance Imaging (MRI)and Brain Electrophysiology Evaluation

NCT01952028 is registered in ClinicalTrials.gov with Cure CMD as lead sponsor.

NCT NCT01952028
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01952028 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A LAMA2-related Muscular Dystrophy Study: Brain Magnetic Resonance Imaging (MRI)and Brain Electrophysiology Evaluation
Lead sponsor
Cure CMD
Phase
Observational
Overall status
Withdrawn
Start date
November 30, 2013
Completion date
December 31, 2014
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lama2-md (merosin deficient congenital muscular dystrophy, mdc1a)